Clinical Studies in Connecticut Join our CommunityNewly Diagnosed? Check out the resources below and learn about APDA's Signature Program for newly diagnosed - PRESS™ (Parkinson’s Roadmap for Education and Support Services™)Parkinson's Education Programs Clinical Trial and Research Information: Check out APDA’s publication “Understanding Clinical Trials: What you need to know” Sacred Heart University Doctor of Physical Therapy Program Do you have Parkinson’s Disease?Consider chair yoga to improve your walking and balance! About the studyWe are looking for people with PD to participate in a research study assessing the benefits of chair yoga on physical function! Join a certified yoga instructor and physcal therapist, along with student researchers, for 1 hour yoga sessions over 8 weeks! View Flyer NEW PD RESEARCH STUDYGait and CognitionSacred Heart University Movement Analysis LabContact Dr. Joshua Lander for more information(203)-226-2366 or josh@LSHS.pro NEW!A Phase II, double-blind, placebo-controlled study to assess the safety and efficacy of ONO-2808 Yale is excited to offer an opportunity for people diagnosed with Multiple System Atrophy to participate in a clinical trial of a new therapy which may reduce the symptoms of the disease! Potential participants must be 60-80 years old and can have MSA-P or MSA-C. Contact: maxine.kuang@yale.edu or by phone at 203-292-0851 NEW! Neurodegenerative Disease Study If you are 40-90 years of age and have been diagnosed with or know someone diagnosed with REM Behavior Disorder, Lewy Body disease or early-stage Parkinson’s disease, you or they may be eligible to participate in this study. The purpose of this research study is to see how these disorders affect brain networks, perception, and cognition. Visits involve medical screening, cognitive tests, and MRI imaging. Contact: fredericks.lab@yale.edu or call 203-737-4630 Do you have Parkinson’s disease and symptoms of depression?Yale UniversityTake part in this research to help in the discovery of new treatments for those fighting against Parkinson’s disease.Contact: ketaminepd@yale.edu or call or text: (475) 287-9521 Link to participate here- Tracing the Origin and Progression of Parkinson’s Disease through the Neuro-Immune Interactome Observational/longitudinal study hypothesizing that in a subset of cases, PD is initiated by an autoimmune process involving alpha-synuclein specific T-cell activation by gut microbiome dysbiosis, followed by neuro-immune interactions that establish the disease in the brain. Contact: Kara.mead@yale.edu NEW! Cognitive Training Study in Parkinson’s Disease To understand the potential mental and brain effects of cognitive training in Parkinson’s disease. Contact: cognitive@yale.edu NEW! Augmentation in Restless Legs Syndrome We are recruiting patients with severe and worsening restless legs syndrome who are taking dopamine agonist medications, including ropinirole (Requip), pramipexole (Mirapex), or the rotigotine patch (Neupro). We will measure levels of particular hormones, called the melanocortin hormones in patients with RLS. Contact: brian.koo@yale.edu NEW! Intestinal Immunity in Neurological Disease If you are due for a routine colonoscopy, you may be eligible for a research study trying to determine the causes of certain neurologic diseases, such as Multiple Sclerosis or Parkinson’s. Participants will undergo tissue biopsies during their routine colonoscopy and will have a blood draw. Anyone who is due for a screening colonoscopy may qualify for the study. Contact: MSResearch@yale.edu SPEAK OUT! is an effective program that combines education, individual, andgroup voice therapy. Sacred Heart University offers this program “FREE”!Please contact Cristina M. Pino, M.A., CCC-SLP at: pinoc5@sacredheart.edu Measuring Synaptic Density in Parkinson’s Disease with SV2A PET Imaging Investigates the changes in synaptic density in individuals with PD by using PET imaging with 11C-UCB-J, a recently developed PET radiotracer that binds to the synaptic vesicle glycoprotein, 2A. Contact: mark.dias@yale.edu NEW! Imaging the Dopamine Transporter in Parkinson’s Disease Use PET imaging to examine in vivo measurement of the dopamine transporter (DAT) in PD and Healthy Control subjects. Contact: mark.dias@yale.edu University of Connecticut, Department of Kinesiology, Program in Physical Therapy. Participants wanted for a research study: Improving Gait and Quality of life in people with Parkinson’s disease through enhanced gait training. Call 860-486-9555 to learn more People with Parkinson’s disease or other forms of parkinsonism have a much higher risk of hip and other fractures. Consider joining a virtual study where you can participate entirely from the comfort of your own home. TOPAZ (Trial of Parkinson’s and Zoledronic Acid) will test if zoledronate, can prevent fractures in people with Parkinson’s disease or other forms of parkinsonism, whether or not they have osteoporosis. You could receive $100 upon enrollment and $50 pear year during the study. For more information, please visit TOPAZstudy.org, or call us directly at (415) 317-5748.
